These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36670271)
1. Best Practices for Submission of NMR Data to Support Higher Order Structure Assessment of Generic Peptide Drugs. Chen K; Smith CJ AAPS J; 2023 Jan; 25(1):17. PubMed ID: 36670271 [No Abstract] [Full Text] [Related]
2. NMR Spectroscopy for Protein Higher Order Structure Similarity Assessment in Formulated Drug Products. Wang D; Zhuo Y; Karfunkle M; Patil SM; Smith CJ; Keire DA; Chen K Molecules; 2021 Jul; 26(14):. PubMed ID: 34299526 [TBL] [Abstract][Full Text] [Related]
3. Development of Calcitonin Salmon Nasal Spray: similarity of peptide formulated in chlorobutanol compared to benzalkonium chloride as preservative. Costantino HR; Culley H; Chen L; Morris D; Houston M; Roth S; Phoenix MJ; Foerder C; Philo JS; Arakawa T; Eidenschink L; Andersen NH; Brandt G; Quay SC J Pharm Sci; 2009 Oct; 98(10):3691-706. PubMed ID: 19226627 [TBL] [Abstract][Full Text] [Related]
4. An NMR-Based Similarity Metric for Higher Order Structure Quality Assessment Among U.S. Marketed Insulin Therapeutics. Wang D; Park J; Patil SM; Smith CJ; Leazer JL; Keire DA; Chen K J Pharm Sci; 2020 Apr; 109(4):1519-1528. PubMed ID: 31927041 [TBL] [Abstract][Full Text] [Related]
5. Application of 2D-NMR with room temperature NMR probes for the assessment of the higher order structure of filgrastim. Brinson RG; Ghasriani H; Hodgson DJ; Adams KM; McEwen I; Freedberg DI; Chen K; Keire DA; Aubin Y; Marino JP J Pharm Biomed Anal; 2017 Jul; 141():229-233. PubMed ID: 28454057 [TBL] [Abstract][Full Text] [Related]
7. NMR investigations of structural and dynamics features of natively unstructured drug peptide - salmon calcitonin: implication to rational design of potent sCT analogs. Rawat A; Kumar D J Pept Sci; 2013 Jan; 19(1):33-45. PubMed ID: 23208874 [TBL] [Abstract][Full Text] [Related]
8. Best Practices in Utilization of 2D-NMR Spectral Data as the Input for Chemometric Analysis in Biopharmaceutical Applications. Brinson RG; Arbogast LW; Marino JP; Delaglio F J Chem Inf Model; 2020 Apr; 60(4):2339-2355. PubMed ID: 32249579 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity risk assessment of synthetic peptide drugs and their impurities. De Groot AS; Roberts BJ; Mattei A; Lelias S; Boyle C; Martin WD Drug Discov Today; 2023 Oct; 28(10):103714. PubMed ID: 37467878 [TBL] [Abstract][Full Text] [Related]
10. Two-dimensional NMR and structure determination of salmon calcitonin in methanol. Meadows RP; Nikonowicz EP; Jones CR; Bastian JW; Gorenstein DG Biochemistry; 1991 Feb; 30(5):1247-54. PubMed ID: 1991104 [TBL] [Abstract][Full Text] [Related]
11. Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states. Neidigh JW; Fesinmeyer RM; Prickett KS; Andersen NH Biochemistry; 2001 Nov; 40(44):13188-200. PubMed ID: 11683627 [TBL] [Abstract][Full Text] [Related]
12. Three-Dimensional Structure Determination of Peptides Using Solution Nuclear Magnetic Resonance Spectroscopy. Schroeder CI; Rosengren KJ Methods Mol Biol; 2020; 2068():129-162. PubMed ID: 31576526 [TBL] [Abstract][Full Text] [Related]
17. Modulating calcitonin fibrillogenesis: an antiparallel alpha-helical dimer inhibits fibrillation of salmon calcitonin. Andreotti G; Motta A J Biol Chem; 2004 Feb; 279(8):6364-70. PubMed ID: 14594801 [TBL] [Abstract][Full Text] [Related]
18. Assessment of higher order structure comparability in therapeutic proteins using nuclear magnetic resonance spectroscopy. Amezcua CA; Szabo CM J Pharm Sci; 2013 Jun; 102(6):1724-1733. PubMed ID: 23568791 [TBL] [Abstract][Full Text] [Related]
19. Rapid and accurate verification of drug identity, purity and quality by Dos Santos Ribeiro HS; Dagnino D; Schripsema J J Pharm Biomed Anal; 2021 May; 199():114040. PubMed ID: 33836463 [TBL] [Abstract][Full Text] [Related]
20. Labelling peptides with fluorescent probes for incorporation into degradable polymers. Brunner A; Minamitake Y; Göpferich A Eur J Pharm Biopharm; 1998 May; 45(3):265-73. PubMed ID: 9653631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]